Fig 4.
Biochemical analysis. Sprifermin-treated constructs had significantly higher total and regional GAG content, as well as significantly higher collagen content in the core of the explant. The total and regional solid volume fractions (dry weight/wet weight) were significantly lower in the control group (n=15-23/group).